Skip to main content

Table 3 Multiple regression model using as dependent variable percent of change in non-HDL cholesterol concentration

From: Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

Variable Beta coefficient ± standard error p value
Constant 14.4 ± 2.6 < 0.001
BMI < 25 kg/m2 7.6 ± 3.6 0.036
Mixed hyperlipidemia 0.82 ± 0.2 0.003
Percent of change of triglycerides 0.68 ± 0.4 < 0.001
  1. Correlation coefficient = 0.647, r2 = 0.419, p = 0.001 BMI, Body mass index